ArticleJournal of gastrointestinal oncology2021

Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma.

Bingjiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.